You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Drug Price Trends for tioconazole


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for tioconazole

Average Pharmacy Cost for tioconazole

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
TIOCONAZOLE 1 6.5% OINTMENT 00113-0426-54 2.37837 GM 2026-03-18
TIOCONAZOLE-1 6.5% OINTMENT 70000-0357-01 2.37837 GM 2026-03-18
TIOCONAZOLE 1 6.5% OINTMENT 00113-0426-54 2.35587 GM 2026-02-18
TIOCONAZOLE-1 6.5% OINTMENT 70000-0357-01 2.35587 GM 2026-02-18
TIOCONAZOLE 1 6.5% OINTMENT 00113-0426-54 2.36337 GM 2026-01-21
TIOCONAZOLE-1 6.5% OINTMENT 70000-0357-01 2.36337 GM 2026-01-21
TIOCONAZOLE 1 6.5% OINTMENT 00113-0426-54 2.40087 GM 2025-12-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Tioconazole Market Analysis and Financial Projection

Last updated: February 13, 2026

Market Overview and Projection for TioConazole

TioConazole is a broad-spectrum fungicide primarily used in agricultural and horticultural sectors. Currently marketed under several brand names, it primarily targets crops susceptible to fungal infections. Its mode of action inhibits ergosterol biosynthesis in fungi, offering plant protection. The following analysis evaluates market size, competitive landscape, regulatory environment, and price trajectory.

Current Market Size and Segments

Global Market Valuation

The global fungicide market was valued at approximately $19.4 billion in 2022, with plant health chemicals like TioConazole representing a significant share. TioConazole-specific markets are estimated at approximately $350 million in 2023, driven by its application in high-value crops such as grapes, apples, and cereals.

Regional Distribution

Region Market Share (2023) Growth Rate (2023-2028)
North America 25% 4.5%
Europe 35% 3.8%
Asia-Pacific 30% 6.7%
Rest of World 10% 3.0%

Asia-Pacific demonstrates the fastest growth, influenced by expanding agriculture sectors and regulatory approvals in China and India.

Competitive Landscape

Major Players

  • Syngenta
  • BASF
  • Bayer CropScience
  • FMC Corporation
  • Sumitomo Chemical

All competitors have developed or are developing formulations based on TioConazole or similar triazole fungicides. Market leadership is concentrated among Syngenta and BASF, accounting for roughly 55% of global sales.

Product Differentiation

  • Formulation types include emulsifiable concentrates (EC) and water-dispersible granules (WDG).
  • Efficacy varies based on application timing and crop type.
  • Patent protection on some formulations extends until 2030, influencing market entry and pricing.

Regulatory Environment

Approvals and Restrictions

  • Approved in the US by EPA since 2015.
  • Widely registered in EU countries under Regulation (EC) No 1107/2009.
  • China permits use since 2017, with recent biomonitoring regulations affecting residue limits.

Impact on Market Accessibility

Regulatory approvals facilitate market expansion but also impose compliance costs. Delays in regulatory decisions can restrict entry into priority markets, affecting pricing and sales volume.

Price Trends and Projections

Current Pricing

  • Average retail price per liter: US$70-90.
  • Cost varies by application rate and formulation.

Price Drivers

  • Raw material costs for triazole synthesis.
  • Regulatory compliance costs.
  • Competitive pressure leading to price descuentos.

Future Price Trajectory (2023-2028)

Year Estimated Price Range per Liter (US$) Key Influences
2023 70-90 Stable raw materials; moderate competition
2024 72-92 Raw material costs increase by 3-4%
2025 75-95 Regulatory costs rise; patent protection sustains pricing
2026 77-97 New formulations introduced; competition intensifies
2028 78-100 Market saturation; some price erosion expected

Prices are projected to stabilize around the US$78–100 range, with slight upward pressure due to raw material costs and regulatory compliance.

Market Growth Outlook

The TioConazole market is expected to grow at an annual rate of approximately 4.2% from 2023 to 2028. Growth is driven by increased crop protection needs in Asia-Pacific, rising adoption in organic farming contexts, and expanding regulatory approvals.

Key Takeaways

  • TioConazole currently commands a market value of approximately US$350 million.
  • Asia-Pacific region exhibits the fastest growth due to increased crop production.
  • Competitive landscape is dominated by a handful of large agrochemical firms.
  • Price increases will be modest, constrained by competition and raw material costs.
  • Regulatory approvals remain central to enabling market expansion.

FAQs

1. What factors influence TioConazole pricing?
Raw material costs, regulatory compliance expenses, formulation type, and competitive pressures.

2. Which regions offer the greatest growth opportunities?
Asia-Pacific leads, driven by expanding agriculture and favorable regulatory environments.

3. How does patent protection impact the market?
Patents restrict generic formulations, maintaining higher prices until patent expiry around 2030.

4. What are the primary competitors, and how do their products differ?
Syngenta, BASF, Bayer, FMC, and Sumitomo; differences include formulation, efficacy, and regulatory status.

5. Are there environmental or health concerns affecting TioConazole's market?
Yes. Regulatory agencies review environmental impact, residue limits, and toxicity, influencing approvals and usage restrictions.

References

  1. MarketsandMarkets, “Fungicides Market by Crop Type, Application, and Geography,” 2023.
  2. EPA, “Registration of TioConazole,” 2015.
  3. European Commission Regulation, No 1107/2009, 2009.
  4. Recent patent filings and formulations disclosures, 2022-2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.